logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yelena Y. Janjigian

Memorial Sloan Kettering Cancer Center
H指数:67
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastrooesophageal junction adenocarcinoma (MATTERHORN) : final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

围术期度伐利尤单抗联合氟尿嘧啶、亚叶酸钙、奥沙利铂和多西他赛治疗可切除胃和胃食管结合部腺癌（MATTERHORN）：一项全球、随机、双盲、安慰剂对照、多中心、III期试验的最终总生存期和无事件生存期结果，按病理反应分层

LANCET
IF0
2026-09-011
PRE
Janjigian, Yelena Y.; Al-Batran, Salah-Eddin; Wainberg, Zev A.; Muro, Kei; Molena, Daniela; Van Cutsem, Eric; Hyung, Woo Jin; Wyrwicz, Lucjan; Oh, Do-Youn; Omori, Takeshi; Moehler, Markus; Bragagnoli, Arinilda C.; Garbaos, Gabriel; Liberman, Moishe; Miron, Maria Luisa Limon; Smyth, Elizabeth C.; Cheng, Lin-Yang; Robbins, Scott H.; Valeri, Nicola; Xynos, Ioannis; Tabernero, Josep
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma

理解TILs: 胃食管癌中肿瘤浸润淋巴细胞形态学评估的建议

Histopathology
IF4.1
2026-02-050
OAAI
Ylva A Weeda; Roberto Salgado; Filip van Herpe; Daniel Sur; Michael Vieth; Sherene Loi; Ahmad P Tafti; Hardas Alexandros; Akira I Hida; Amarpreet Bhalla; Andrey I Khramtsov; Anna Ehinger; Atsushi Tanaka; Balazs Acs; Caner Ercan; Cornelia M Focke; Daniel Ehinger; Dan Huang; Galina F Khramtsova; Haruto Nishida; Nianyi Li; Nickolas Littlefield; Sanna Steen; Selim Sevim; Shin Ichihara; Shinnosuke Morikawa; Stefan Michiels; Thomas Papathomas; Toshihiro Haga; Qiangqiang Gu; Weiqi Sheng; Hoel Kervadec; Hugo M Horlings; Francisco Sanchez-Vega; Yelena Y Janjigian; Myriam Chalabi; Hanneke W M van Laarhoven; Liudmila L Kodach; Sybren L Meijer
Genomic and clinical parallels between US and Japanese gastric cancers: a propensity score-matched cohort study

美国与日本胃癌的基因组学和临床平行性：一项倾向性评分匹配队列研究

BJS-BRITISH JOURNAL OF SURGERY
IF0
2025-12-010
PRE
Nakauchi, Masaya; Court, Colin; Walch, Henry S.; Abate, Miseker; Shimada, Shoji; Chatila, Walid K.; Tang, Laura H.; Coit, Daniel G.; Janjigian, Yelena Y.; Maron, Steven B.; Ku, Geoffrey Y.; Ilson, David H.; Schultz, Nikolaus; Matsuoka, Hiroshi; Tsukamoto, Tetsuya; Uyama, Ichiro; Suda, Koichi; Strong, Vivian E.
Progression-Free Survival as a surrogate for Overall Survival in gastro-esophageal cancer trials with immunotherapy: a meta-analysis

无进展生存期作为免疫治疗在胃肠癌临床试验中总体生存期的替代指标：一项荟萃分析

European Journal of Cancer
IF7.1
2025-11-290
OAAI
Alberto Giovanni Leone; Fausto Petrelli; Samuel J. Klempner; Elizabeth C. Smyth; Raghav Sundar; Florian Lordick; Sylvie Lorenzen; Micheal Masetti; Radka Obermannova; Maria Alsina; Yelena Y Janjigian; Filippo Pietrantonio
Electro-acupuncture for quality of life during adjuvant chemotherapy in gastric cancer: a randomized trial

胃癌辅助化疗期间的生活质量电针疗法：一项随机试验

JNCI: Journal of the National Cancer Institute
IF0
2025-10-270
OA
Yan-Juan Zhu, MD; Xue-Song Chang, MM; Xiao-Yu Wu, MD; Wei Wang, MD; De-Chang Diao, MD; Yong Li, MD; Hong-Yu Zhang, MD; Jian Xiao, MD; Xiao-Hui Zhai, MD; Jin-Long Yu, MD; Wei Wang, MD; Jing-Xu Zhou, MD; Zhi-Liang Huang, MD; Tao Zhang, MB; Wenwei Ouyang, MD; Yelena Y Janjigian, MD; Samuel L Cytryn, MD; Zhen-Zhen Xiao, MM; Yi-Hong Liu, MM; Rui Zhou, MD; Hao-Chuan Ma, MD; Ya-Dong Chen, MM; Jian-Jun Peng, MD; Jun J Mao, MD; Hai-Bo Zhang, MD; null
Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial

帕博利珠单抗联合曲妥珠单抗和化疗治疗HER2阳性晚期胃癌：来自随机KEYNOTE-811试验的健康相关生活质量分析

ESMO Open
IF8.3
2025-09-300
OAAI
Y.Y. Janjigian; A. Kawazoe; J. Xu; S. Lonardi; J.-P. Metges; L.S. Wyrwicz; L. Shen; Y. Ostapenko; M. Bilici; M.A. Lowery; A. Valderrama; Y. Guan; K. Li; C.-S. Shih; S.Y. Rha
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial

纳武利尤单抗联合化疗或伊匹木单抗治疗胃癌和食管癌：一项随机III期试验的探索性生物标志物分析

NATURE MEDICINE
IF50
2025-03-070
OA
Shitara, Kohei; Janjigian, Yelena Y.; Ajani, Jaffer; Moehler, Markus; Yao, Jin; Wang, Xuya; Chhibber, Aparna; Pandya, Dimple; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yanez, Patricio; Kowalyszyn, Ruben; Karamouzis, Michalis; Zander, Thomas; Feeney, Kynan; Elimova, Elena; Doshi, Parul; Li, Mingshun; Lei, Ming
TroFuse-015: A phase III study of trophoblast antigen 2 (TROP2)edirected antibody-drug conjugate sacituzumab tirumotecan (sac-TMT) vs treatment of physician's choice (TPC) for previously treated metastatic gastroesophageal adenocarcinoma (GEA)

TroFuse-015: 一项关于滋养层抗原2（TROP2）导向抗体药物偶联物sacituzumab tirumotecan（sac-TMT）与治疗医师选择方案（TPC）对比的III期研究，用于先前治疗过的转移性胃食管腺癌（GEA）。

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Shitara, K.; Wainberg, Z. A.; van Cutsem, E.; Janjigian, Y. Y.; Xu, R-H.; Oh, D-Y.; Xu, J.; Wu, S.; Bhaumik, S.; Bhagia, P.; Tabernero, J.
Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+advanced, unresectable or metastatic G/GEJ adenocarcinoma

KEYNOTE-811研究的III期最终总生存数据，该研究评估了帕博利珠单抗联合曲妥珠单抗和化疗治疗HER2阳性、不可切除或转移性胃/胃食管结合部腺癌。

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Rha, S. Y.; Kawazoe, A.; Bai, Y.; Xu, J.; Lonardi, S.; Metges, J-P.; Weber, P. E. Yanez; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y. V.; Bilici, M.; Chung, H. C.; Shitara, K.; Mahave, M.; van Cutsem, E.; Tabernero, J.; Xu, L.; Sharan, K. P.; Bhagia, P.; Janjigian, Y. Y.
Esophagectomy may have a role in stage IV esophageal adenocarcinoma

食管切除术可能在IV期食管腺癌中发挥作用。

thoracic and cardiovascular surgery
IF0
2024-11-220
PRE
Marisa Sewell; Nicolas Toumbacaris; Kay See Tan; Nadia Bahadur; John Philip; Neil J. Shah; Andrew Niederhausern; Carlos Tavarez Martinez; Haiyu Zheng; Thomas Boerner; Yelena Y. Janjigian; Steve B. Maron; Matthew J. Bott; Katherine D. Gray; Bernard J. Park; Smita Sihag; David R. Jones; Geoffrey Y. Ku; Abraham J. Wu; Daniela Molena
Datopotamab deruxtecan (Dato-DXd) in patients with endometrial (EC) or ovarian cancer (OC): Results from the phase II TROPION-PanTumor03 study

Datopotamab deruxtecan (Dato-DXd) 在子宫内膜癌 (EC) 或卵巢癌 (OC) 患者中的应用：来自 TROPION-PanTumor03 II 期研究的结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Oaknin, A.; Ang, J. E.; Rha, S. Y.; Yonemori, K.; Kristeleit, R.; Lin, C-C.; Satoh, T.; Garcia, P. Estevez; Sendur, M. A. N.; Rodriguez, L. Medina; Italiano, A.; Lugowska, I.; Ray-Coquard, I. L.; Oza, A. M.; Zhao, J. L.; Gajavelli, S.; Filant, J.; Bodla, S.; Janjigian, Y. Y.; Meric-Bernstam, F.

研究方向

暂未获取到该数据
G
Geoffrey Y. Ku
H 指数:37论文数:527被引数:1.2万
L
Laura H. Tang
H 指数:83论文数:542被引数:3.0万
V
Vivian E. Strong
H 指数:55论文数:394被引数:1.5万
D
David H. Ilson
H 指数:67论文数:924被引数:2.0万
D
Daniela Molena
H 指数:46论文数:475被引数:8,479
D
Daniel G. Coit
H 指数:99论文数:507被引数:4.1万
K
Kohei Shitara
H 指数:79论文数:1,129被引数:3.5万
S
Steven B. Maron
H 指数:24论文数:358被引数:2,661
J
Josep Tabernero
H 指数:146论文数:2,711被引数:12.7万
A
Abraham J. Wu
H 指数:46论文数:483被引数:9,388